921 - 930 of 4301 Drugs
Breo Ellipta (fluticasone furoate and vilanterol inhalation powder)
Breo Ellipta (fluticasone furoate and vilanterol) is a combination inhaled corticosteroid (ICS) and long-acting beta2-adrenergic agonists (LABA) used to treat airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Breo Ellipta is also used to reduce exacerbations (sudden worsening) of COPD in patients with a history of exacerbations.
Bretylium (bretylium tosylate injection)
Bretylium (bretylium tosylate) injection is an antiarrhythmic drug used in emergency medicine, cardiology, and other specialties for treatment of severely abnormal heart rhythm (ventricular fibrillation) and fast heartbeat (tachycardia). Bretylium has been discontinued, but generics may be available.
Brevibloc (esmolol)
Brevibloc Premixed (esmolol hydrochloride) Injection is a beta-blocker indicated for the rapid control of ventricular rate in patients with atrial fibrillation, or atrial flutter in perioperative, postoperative, or other emergent circumstances. Brevibloc is also indicated in noncompensatory sinus tachycardia where the rapid heart rate requires specific intervention. Brevibloc is available in generic form.
Brevicon (norethindrone and ethinyl estradiol tablets)
Brevicon (norethindrone and ethinyl estradiol) is a combination of female hormones used as contraception to prevent pregnancy. Brevicon is also used to treat severe acne.
Brevital Sodium (methohexital sodium for injection)
Brevital Sodium (methohexital sodium for injection) is a barbiturate used to make you fall asleep before a surgery or other medical procedure. Brevital Sodium is usually given in combination with other types of anesthesia.
Zulresso (brexanolone injection, for intravenous use)
Zulresso (brexanolone) Injection is a type of antidepressant called a neuroactive steroid gamma-aminobutyric acid (GABA) A receptor positive modulator indicated for the treatment of postpartum depression (PPD) in adults. Zulresso is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the Zulresso REMS.
Rexulti (brexpiprazole tablets)
Rexulti (brexpiprazole) is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD), for treatment of schizophrenia in adults and pediatric patients ages 13 years and older, and for treatment of agitation associated with dementia due to Alzheimer’s disease.
Tecartus (brexucabtagene autoleucel suspension)
Tecartus (brexucabtagene autoleucel) is a CD19-directed genetically modified autologous T cell immunotherapy used to treat adult patients with relapsed or refractory mantle cell lymphoma (MCL).
Breyanzi (lisocabtagene maraleucel suspension for intravenous infusion)
Breyanzi (lisocabtagene maraleucel) is a CD19-directed genetically modified autologous T cell immunotherapy used to treat adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified (including DLBCL arising from indolent lymphoma), high-grade B-cell lymphoma, primary mediastinal large B-cell lymphoma, and follicular lymphoma grade 3B.